AAM Criticizes Lower Health Care Costs Act

Over Inclusion Of ‘Blocking Act’ Reforms To 180-Day Exclusivity

Reforms to the US 180-day exclusivity incentive included in the Blocking Act that is part of the Lower Health Care Costs Act could cost the US healthcare system approximately $1.7bn, the AAM has warned.

USA_Healthcare
The AAM has encouraged Congress to oppose the Lower Health Care Costs Act • Source: Shutterstock

More from Policy & Regulation

More from Generics Bulletin